Braun Stacey Associates Inc Vertex Pharmaceuticals Inc Transaction History

Braun Stacey Associates Inc

$2.54 Billion
Q3 2024

A detailed history of Braun Stacey Associates Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Braun Stacey Associates Inc holds 51,497 shares of VRTX stock, worth $23.9 Million. This represents 0.94% of its overall portfolio holdings.

Number of Shares

51,497

Previous 56,858 9.43%

Holding current value

$23.9 Million

Previous $26.7 Million 10.13%

% of portfolio

0.94%

Previous 0.92%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$460.0 - $505.78 $2.47 Million - $2.71 Million	-5,361 Reduced 9.43%	51,497 $24 Million
Q2 2024 Jul 29, 2024	SELL	$392.81 - $485.53 $1.05 Million - $1.29 Million	-2,664 Reduced 4.48%	56,858 $26.7 Million
Q1 2024 Apr 30, 2024	SELL	$407.69 - $446.08 $327,375 - $358,202	-803 Reduced 1.33%	59,522 $24.9 Million
Q4 2023 Jan 23, 2024	SELL	$343.0 - $410.68 $191,051 - $228,748	-557 Reduced 0.91%	60,325 $24.5 Million
Q3 2023 Nov 21, 2023	SELL	$338.18 - $362.46 $58,505 - $62,705	-173 Reduced 0.28%	60,882 $21.2 Million
Q2 2023 Jul 28, 2023	SELL	$314.42 - $351.91 $11.2 Million - $12.5 Million	-35,615 Reduced 36.84%	61,055 $21.5 Million
Q1 2023 May 08, 2023	BUY	$283.23 - $323.1 $27.4 Million - $31.2 Million	96,670 New	96,670 $30.5 Million
Q4 2020 Feb 03, 2021	SELL	$207.01 - $276.09 $13.5 Million - $18 Million	-65,312 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$255.65 - $303.1 $171,285 - $203,077	-670 Reduced 1.02%	65,312 $17.8 Million
Q2 2020 Aug 06, 2020	BUY	$225.48 - $295.8 $1.6 Million - $2.1 Million	7,099 Added 12.06%	65,982 $19.2 Million
Q1 2020 Jun 09, 2020	BUY	$199.77 - $247.81 $11.8 Million - $14.6 Million	58,883 New	58,883 $14 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Braun Stacey Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Braun Stacey Associates Inc with notifications on news.

Account

Braun Stacey Associates Inc Vertex Pharmaceuticals Inc Transaction History